Goldina Erowele

Bio

Dr Erowele, clinical pharmacist and cofounder at CareNovateMag.com [http://www.carenovatemag.com], a free caregiving, social health and medication literacy web-resource. CareNovateMag.com provides timely, relevant and doable information to help family & professional caregivers, patients, families, healthcare extenders, consumers, seniors and most of all WOMEN with health, wellness and caregiving. CareNovateMag.com offers also offers instructive content through their twice weekly email communications and newsletter. Prior to pharmacy, Dr Erowele was a certified nursing assistant (CNA), passionate about helping the senior and elderly population. Attended Howard University College of Pharmacy and completed a year pharmacy practice residency program at the VAMC in Washington, D.C. Practiced at the Walter Reed Army Medical Center as a pharmacotherapy specialist in areas of geriatrics, formulary management, internal medicine, intensive care. While there, she had spearheaded, developed and implemented clinical pharmaceutical services.

As a clinical pharmacy specialist, she also manages & cordinates a multi-million hematology oncology pharmaceutical budget in a Houston, TX Hospital.  She serves as an adjunct professor at the College of Pharmacy & Health Sciences, where she lectures on various topics. She has authored and coauthored several pharmacy journals, book chapters and serves as a reviewer to multiple journals. She received the U.S. Army Commander’s Award for Civilian Service in 2005 and 2006 & the 2007 Mel Liter Clinical Pharmacy Award.  She is a member of the Kappa Epsilon Society (an honor society for pharmacy professions), a wife, sister, mom and a friend.

Specialties:

Affiliation:

  • CareNovateMag

Location:

Activity

  • Sharecare News
    Sharecare News posted a story about Psychiatry:

    THURSDAY, Aug. 21, 2014 (HealthDay News) -- A combination of therapy and antidepressants appears to best help people with severe but short-term depression, a new study reports.

    Four out of five people suffering from severe depression for less than two years experienced full recovery when ...Full Article

  • Sharecare News
    Sharecare News posted a story about Infectious Disease:

    THURSDAY, Aug. 21, 2014 (HealthDay News) -- An experimental drug shows promise in treating respiratory syncytial virus (RSV), a leading cause of pneumonia in infants, researchers report.

    "We are finally making major progress in being able to treat human RSV infections -- the world's secon...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Loss of brain cells that act as a "sleep switch" may help explain why many seniors have trouble falling and staying asleep, a new study suggests.

    In Alzheimer's patients, sleep disruption can be especially severe and often results in nighttime ...Full Article

  • Sharecare News
    Sharecare News posted a story about Pharmacy:

    WEDNESDAY, Aug. 20, 2014 (HealthDay News) -- Cerdelga (eliglustat) has been approved by the U.S. Food and Drug Administration to treat type 1 Gaucher disease, a rare inherited disorder caused by the body's insufficient production of a key enzyme.

    Lack of the enzyme glucocerebrosidase caus...Full Article

  • Sharecare News
    Sharecare News posted a story about Caregiving:

    TUESDAY, Aug. 19, 2014 (HealthDay News) -- It's no secret that daughters seem to bear the brunt of caregiving duties for elderly parents, but a new study suggests that conscientious daughters often fill the gaps left by sons.

    "Sons provide a lower relative share of total parent care if th...Full Article

  • Sharecare News
    Sharecare News posted a story about Cosmetology:

    SUNDAY, Aug. 17, 2014 (HealthDay News) -- A drug used to treat a rare type of bone marrow cancer restores hair in patients with an autoimmune disease that causes hair loss, a new study found.

    Columbia University Medical Center researchers found that the drug rux...Full Article

  • Sharecare News
    Sharecare News posted a story about Public Health:

    FRIDAY, Aug. 15, 2014 (HealthDay News) -- As the death toll in the West Africa Ebola outbreak passes 1,000, the U.S. Food and Drug Administration is warning against products sold online that claim to treat the deadly disease or prevent infection.

    Since the start of the Ebola outbreak in...Full Article

  • Sharecare News
    Sharecare News posted a story about Public Health:

    FRIDAY, Aug. 15, 2014 (HealthDay News) -- As the death toll in the West Africa Ebola outbreak passes 1,000, the U.S. Food and Drug Administration is warning against products sold online that claim to treat the deadly disease or prevent infection.

    Since the start of the Ebola outbreak in...Full Article

  • Sharecare News
    Sharecare News posted a story about Pharmacy:

    WEDNESDAY, Aug. 13, 2014 (HealthDay News) -- A new prescription insomnia drug that's the first of its kind was approved by the U.S. Food and Drug Administration on Wednesday.

    Belsomra (suvorexant) tablets are approved to treat patients with insomnia, which means they have difficulty falli...Full Article

  • Sharecare News
    Sharecare News posted a story about Infectious Disease:

    WEDNESDAY, Aug. 13, 2014 (HealthDay News) -- The high-dose flu shot protects seniors better than the standard dose does, a new study finds.

    About one in four cases of flu in older patients vaccinated with the standard dose could be prevented if the high-dose vaccine were used instead, the...Full Article

  • Sharecare News
    Sharecare News posted a story about Infectious Disease:

    TUESDAY, Aug. 12, 2014 (HealthDay News) -- A panel of ethicists specially appointed by the World Health Organization says it is ethical to give untested treatments to people battling Ebola in the current outbreak.

    "In the particular circumstances of this outbreak, and provided certain con...Full Article

  • Sharecare News
    Sharecare News posted a story about Dermatology:

    THURSDAY, Aug. 7, 2014 (HealthDay News) -- The antibacterial drug Orbactiv (oritavancin) has been approved by the U.S. Food and Drug Administration to treat drug-resistant skin infections in adults, the agency said in a news release.

    The drug is sanctioned to treat methicillin-resistant <...Full Article

  • Sharecare News
    Sharecare News posted a story about Neurology:

    WEDNESDAY, Aug. 6, 2014 (HealthDay News) Another study confirms that "time is brain" when treating stroke patients with a powerful clot-busting drug, tPA.

    Prompt treatment with tissue plasminogen activator (tPA, also known as alteplase) "is a very effective means of limiting the degree o...Full Article

  • Sharecare News
    Sharecare News posted a story about Gerontology:

    WEDNESSDAY, Aug. 6, 2014 (HealthDay News) -- As many as one in 20 older adults in the United States may be financially exploited, a new study suggests.

    In fact, most older adults have had their money or property stolen or used improperly at some point, the researchers found. What's wors...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    WEDNESDAY, Aug. 6, 2014 (HealthDay News) -- Taking aspirin every day appears to reduce the odds of developing and dying from colon, stomach or esophageal cancer, a new study suggests.

    Based on a review of available studies, researchers determined that the benefi...Full Article